Keyword Object / Regions / Find Information / ISN

Find information

Information on "Health and Medical Research "

1 2 ... 12 13

Jun 2012
When Modern Science Meets Traditional Knowledge
Author: Thomas R Eimer
Publisher: Center for Transnational Relations, Foreign and Security Policy (ATASP)
In this paper, the complex interactions that are associated with the access to traditional knowledge of local biodiversity shall be regarded as a multi-level process of adaptation and resistance. More on «When Modern Science Meets Traditional Knowledge»
Jun 2012
Role and Potential Influence of Technologies on the Most Relevant Challenges for Long-Term Care
Author: Marta Mazzeo, Patrizia Agnello, Angelo Rossi Mori
Publisher: Centre for European Policy Studies (CEPS)
This report considers three case studies, with the aim of establishing a framework to assess the systemic influence of technologies on the long-term care. More on «Role and Potential Influence of Technologies on the Most Relevant Challenges for Long-Term Care»

18 May 2012
How FDA Approves Drugs and Regulates their Safety and Effectiveness
Author: Susan Thaul
Publisher: US Government
This research report discusses the role of the Food and Drug Administration in regulating the safety and effectiveness of drugs sold in the US. More on «How FDA Approves Drugs and Regulates their Safety and Effectiveness»

Apr 2012
Projections of Use and Supply of Long-Term Care in Europe: Policy Implications
Author: Joanna Geerts, Peter Willemé
Publisher: Centre for European Policy Studies (CEPS)
This policy brief presents results of projections of use and supply of long-term care for older persons in four representative countries: Germany, the Netherlands, Spain and Poland. More on «Projections of Use and Supply of Long-Term Care in Europe: Policy Implications»

Feb 2012
Health-insurance Coverage for Low-wage Workers, 1979-2010 and Beyond
Author: John Schmitt
Publisher: Center for Economic and Policy Research (CEPR)
This paper seeks to provide a complete picture of trends in health-insurance coverage for workers, especially low-wage workers, in the United States over the specified period. More on «Health-insurance Coverage for Low-wage Workers, 1979-2010 and Beyond»

31 Oct 2011
Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases
Author: CGD Working Group on Clinical Trials and Regulatory Pathways
Publisher: Center for Global Development (CGD)
This report provides practical policy recommendations to help deliver better, safer, and cheaper medicine and treatment to the 1 billion people suffering from neglected diseases. More on «Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases»
Oct 2011
Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases
Author: Thomas Bollyky, Amanda Glassman
Publisher: Center for Global Development (CGD)
For many neglected diseases, the drug and vaccine candidates now in the pipeline are the first new therapies and prevention tools in a generation; for others, they are simply the first ever. More on «Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases»
Oct 2011
Achieving an AIDS Transition: Preventing Infections to Sustain Treatment
Author: Mead Over
Publisher: Center for Global Development (CGD)
An unprecedented surge in donor support for HIV/AIDS treatment over the last decade has lengthened and improved the lives of millions of people living with HIV/AIDS. More on «Achieving an AIDS Transition: Preventing Infections to Sustain Treatment»

Sep 2011
Evaluating Health Research Funding in Ireland
Author: Edward Nason, Brendan Curran, Stephen Hanney, Barbara Janta, Gillian Hastings, Mairéad O’Driscoll, Steven Wooding
Publisher: Institute on Governance (IOG)
The Health Research Board (HRB) has funded research in Ireland for over 20 years. More on «Evaluating Health Research Funding in Ireland»
Sep 2011
Drug Pricing: Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement
Author: Debra A Draper
Publisher: US Government Accountability Office (GAO), Washington, DC
The Health Resources and Services Administration (HRSA) oversees the 340B Drug Pricing Program through which participating drug manufacturers give certain entities within the health care safety net access to discounted prices on outpatient drugs. More on «Drug Pricing: Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement»

1 2 ... 12 13